Pharmaceutical Chemical

  1. Home
  2. Products
  3. Health & Medicine
  4. Pharmaceutical Chemical

Share us

Lapatinib Ditosylate

Send Inquiry

Description

Lapatinib is a promising new breast cancer medication. It is an oral therapy targeting intracellular components of a receptor known as ErbB2 and a second receptor, ErbB1, which have been implicated in the growth of various tumor types. Early tests have shown excellent results in treatment of breast cancer, and researchers hope to try Lapatinib on other solid tumor cancers.
Chemical Name: N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine Bis(4-methylbenzenesulfonate) monohydrate
Appearance: Yellow crystalline powder.

CAS No.: [388082-78-8]

Identification: H-1 NMR spectrum-Conforms.

Melting Point: Min240鈩?(decompose)

Water:1.5%-2.5%.

Assay (HPLC):Min98.5%

Sorafenib, Sorafenib,

Read More

Previous

Sorafenib Tosylate...

Shanghai Yingxuan Chempharm Co., Ltd.

Sorafenib Tosylate

Address: RM431 of BLDG 1,No.2588,Jinhai Road,Pudong New District, Shanghai,CN-201209,China,
Shanghai, Shanghai
China, 201209

Tel: :+86-21-60875125
Fax:

H5响应式定制设计
26种语言,SEO营销型网站

H5/响应式/营销型企业网站; 26种语言扩展;
覆盖: 英文、法语、德语、西班牙语、葡萄牙语、俄语、阿拉伯语、波斯语、日语、韩语
了解更多